Valuation Fate Therapeutics, Inc.

Stocks

Delayed Nasdaq Other stock markets 15:47:20 2026-08-03 EDT			5-day change	1st Jan Change
2.475 ^USD	+1.02%		+1.85%	+151.88%

07-09	Fate Therapeutics Shares Rise After FDA Clears Investigational New Drug Application for FT839	MT
07-09	Fate Therapeutics Receives FDA Clearance Of Investigational New Drug Application For FT839 Product Candidate	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,587	980.4	368.8	187.9	113.3	285.6	-	-
Change	-	-82.45%	-62.39%	-49.04%	-39.69%	151.95%	-	-
Enterprise Value (EV)	4,971	544.2	53.6	-118.8	113.3	285.6	285.6	285.6
Change	-	-89.05%	-90.15%	-321.66%	195.41%	151.95%	0%	0%
P/E	-26.1x	-3.47x	-2.28x	-1.01x	-0.85x	-2.26x	-2.38x	-2.28x
PBR	8.25x	2.03x	0.98x	0.59x	-	-	-	-
PEG	-	-0.1x	0.1x	-	0x	0.38x	0.51x	-0.52x
Capitalization / Revenue	100x	10.2x	5.8x	13.8x	17.1x	54.4x	54.5x	65.3x
EV / Revenue	0x	0x	0x	-0x	0x	54.4x	54.5x	65.3x
EV / EBITDA	-0x	-0x	-0x	0x	-0x	-2.08x	-1.86x	-
EV / EBIT	-0x	-0x	-0x	0x	-0x	-2.02x	-1.82x	-1.59x
EV / FCF	-0x	-0x	-0x	0x	-0x	-2.84x	-2.31x	-2.13x
FCF Yield	-3.82%	-28.9%	-37.5%	-65.8%	-98.8%	-35.3%	-43.3%	-47%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.24	-2.91	-1.64	-1.64	-1.15	-1.082	-1.031	-1.076
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	55.85	96.3	63.53	13.63	6.646	5.247	5.236	4.375
EBITDA ¹	-211.1	-294.6	-172.2	-191.3	-134.8	-137	-153.2	-
EBIT ¹	-217	-308.4	-190.5	-210.3	-147.7	-141.3	-156.7	-179.8
Net income ¹	-212.2	-281.7	-160.9	-186.3	-136.3	-132.7	-148	-173.4
Net Debt	-615.9	-436.2	-315.2	-306.7	-	-	-	-
Reference price ²	58.510	10.090	3.740	1.650	0.983	2.450	2.450	2.450
Nbr of stocks (in thousands)	95,494	97,170	98,602	113,894	115,352	116,559	-	-
Announcement Date	2/28/22	2/28/23	2/26/24	3/5/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FATE THERAPEUTICS, INC.	-2.26x	-	-	-.--%	286M
WUXI APPTEC CO., LTD.	21.25x	6.51x	14.24x	1.5%	56.54B
ARGENX SE	31.6x	7.8x	24.02x	0.05%	53.6B
BIONTECH SE	-17.91x	4.18x	-7.32x	-.--%	22.91B
INSMED INCORPORATED	-38.06x	12.21x	-36.05x	-.--%	21.37B
WUXI BIOLOGICS (CAYMAN) INC.	25.45x	4.98x	13.18x	-.--%	20.27B
GENMAB A/S	24.28x	4.73x	15.36x	-.--%	17.56B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-737.38x	35.03x	-3943.97x	-.--%	14.75B
PHARMAESSENTIA CORPORATION	40.7x	16.37x	42.16x	0.09%	13.53B
EXELIXIS, INC.	16.73x	4.82x	11.24x	-.--%	13.33B
Average	-63.56x	10.74x	-429.68x	0.16%	23.41B
Weighted average by Cap.	-31.98x	9.11x	-238.39x	0.38%